Adverse ReNal OuTcomEs in patients with NoN-Valvular Atrial fibrillation treated with Rivaroxaban or Vitamin K Antagonists (ANTENNA)

05/03/2020
29/03/2024
EU PAS number:
EUPAS33537
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Study 21347_Study protocol_Version 1_02Feb2020

English (1.51 MB - PDF) View document
Study results
Study results

21347_EU PAS Abstract_redacted_V1.0_2021-04-27

English (303.9 KB - PDF) View document
Study report
Study report

21347_Study Report_redacted_V1.0_2021-04-27

English (1.14 MB - PDF) View document
Other information